Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -30.13% | 45.15% | -10.18% | 33.96% | 235.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -30.13% | 45.15% | -10.18% | 33.96% | 235.27% |
| Cost of Revenue | 1.90% | -1.50% | -28.80% | 57.93% | 65.68% |
| Gross Profit | -41.39% | 138.07% | 15.15% | 17.93% | 423.47% |
| SG&A Expenses | -33.03% | 14.61% | -19.98% | 7.67% | 61.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.53% | 4.48% | -22.46% | 26.74% | 57.24% |
| Operating Income | -63.31% | 170.56% | 124.35% | 274.59% | 313.27% |
| Income Before Tax | -66.08% | -70.91% | 131.49% | 1,097.44% | 288.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -66.08% | -78.32% | 131.49% | 1,097.44% | 288.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.08% | -78.32% | 131.49% | 1,097.44% | 288.55% |
| EBIT | -63.31% | 170.56% | 124.35% | 274.59% | 313.27% |
| EBITDA | -56.32% | 217.26% | 260.34% | 103.59% | 406.54% |
| EPS Basic | -65.91% | -77.98% | 130.95% | 900.00% | 288.57% |
| Normalized Basic EPS | -66.27% | 167.57% | 111.54% | 1,200.00% | 288.64% |
| EPS Diluted | -67.42% | -77.98% | 128.89% | 900.00% | 278.38% |
| Normalized Diluted EPS | -66.27% | 167.57% | 111.54% | 1,200.00% | 288.64% |
| Average Basic Shares Outstanding | -1.10% | -0.51% | -0.51% | -0.72% | -0.12% |
| Average Diluted Shares Outstanding | -0.63% | 0.03% | 0.06% | -5.12% | -0.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
